🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the hemostatic efficacy of andexa...
Status
Completed
Location
Clinical Study Site
Start Date
2015-04-10
Trial ID
NCT02329327
Treatments Being Tested
This is a randomized, double-blind, single center study in healthy voluntee...
Status
Terminated
Location
WCCT Global
Start Date
2015-08-06
Trial ID
NCT03330457
Treatments Being Tested
The purpose of this study is to evaluate the ability of PRT064445 to revers...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT03551743
Treatments Being Tested
The purpose of this study is to characterize andexanet posology and interac...
Status
Completed
Location
Research Site
Start Date
2026-01-19
Trial ID
NCT07312851
Treatments Being Tested
The purpose of this study is to evaluate the ability of Andexanet Alfa to r...
Status
Completed
Location
West Coast Clinical Trials
Start Date
2014-05
Trial ID
NCT02220725
The study will aim to find out if the drug andexanet alfa is safe and effec...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-08-02
Trial ID
NCT05926349
Treatments Being Tested
The purpose of this study is to evaluate the ability of PRT064445 to revers...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT03551730
Treatments Being Tested
The purpose of this study is to evaluate the ability of PRT064445 to revers...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT03578146
Treatments Being Tested
The purpose of this study is to evaluate the ability of PRT064445 to revers...
Status
Completed
Location
Multiple Locations
Start Date
2012-12
Trial ID
NCT01758432
Treatments Being Tested